We could hear about EMA filing any day now and should hear something back from FDA on recent NDA submission (probably within the next two weeks). Phase II Zerrenex study due to release results around Nephrology conference which is early November. Japanese Phase III trials due out early in 2014. Is that about right?
Wrong! It looks like Keryx had $87.3 million available at the end of last quarter. Assuming that its average burn rate stays constant, Keryx can comfortably cover its expenses for almost five years. Company is in great financial shape!
agree. I did quite a bit of research on JT & Torri and was impressed. Torri is capable of producing and distributing Zerenex at any level, think its called 751 or something. We should hear news in the near future. Both companies really stepped up during the tsunami recovery efforts which gained much favor with the government & people which can only help. Looking good with prospects in Europe as well.